Oka S, Arita H
Shionogi Research Laboratories, Shionogi & Co., Ltd., Osaka, Japan.
J Biol Chem. 1991 May 25;266(15):9956-60.
Inflammatory factors such as tumor necrosis factor (TNF), interleukin 1 (IL-1), and lipopolysaccharide (LPS) greatly enhance the expression of group II phospholipase A2 (PLA2-II) mRNA, leading to increased secretion of PLA2-II enzyme from rat-cultured astrocytes. The potent antiinflammatory agent dexamethasone suppressed the PLA2-II expression induced by LPS. In vivo studies also demonstrated that the level of PLA2-II mRNA in the brain increased with intravenous injection of LPS. These results suggest that PLA2-II in the brain plays important roles in the inflammatory response. Agents which increase intracellular cAMP concentration did not stimulate PLA2-II expression by themselves but selectively enhanced TNF-induced PLA2-II expression about 5-fold. Phorbol ester, a well known protein kinase C activator, increased the PLA2-II expression. H-7, a protein kinase C inhibitor, inhibited the LPS-induced PLA2-II expression, but did not inhibit the TNF-induced one. Therefore, we conclude that the TNF-activated pathway differs from the LPS-activated one: the former is enhanced by cAMP and the latter involves protein kinase C.
肿瘤坏死因子(TNF)、白细胞介素1(IL-1)和脂多糖(LPS)等炎症因子可极大地增强Ⅱ型磷脂酶A2(PLA2-II)mRNA的表达,导致大鼠培养星形胶质细胞分泌的PLA2-II酶增加。强效抗炎药地塞米松可抑制LPS诱导的PLA2-II表达。体内研究还表明,静脉注射LPS后,脑中PLA2-II mRNA水平升高。这些结果表明,脑中的PLA2-II在炎症反应中起重要作用。增加细胞内cAMP浓度的药物本身不会刺激PLA2-II表达,但可选择性地将TNF诱导的PLA2-II表达增强约5倍。佛波酯是一种著名的蛋白激酶C激活剂,可增加PLA2-II表达。蛋白激酶C抑制剂H-7可抑制LPS诱导的PLA2-II表达,但不抑制TNF诱导的表达。因此,我们得出结论,TNF激活的途径与LPS激活的途径不同:前者被cAMP增强,后者涉及蛋白激酶C。